Comparison of the effects of a cell saver and low-dose aprotinin on blood loss and homologous blood usage in patients undergoing valve surgery.
暂无分享,去创建一个
D. Tempe | S. Virmani | D. Ghambeer | A. Banerjee | N. Mehta | S. Panwar | A. Tomar | M. Nigam
[1] M. Prins,et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints , 1999, The Lancet.
[2] J. Levy,et al. Case 3--1999. Intraoperative coronary thrombosis in association with low-dose aprotinin therapy. , 1999, Journal of cardiothoracic and vascular anesthesia.
[3] G. Escolar,et al. Platelet function during cardiac surgery and cardiopulmonary bypass with low-dose aprotinin. , 1999, Journal of cardiothoracic and vascular anesthesia.
[4] W. White,et al. Cost‐Benefit and Efficacy of Aprotinin Compared with ε‐Aminocaproic Acid in Patients Having Repeated Cardiac Operations: A Randomized, Blinded Clinical Trial , 1997 .
[5] P. Dryden,et al. Beneficial effect of both tranexamic acid and aprotinin on blood loss reduction in reoperative valve replacement surgery. , 1997, Circulation.
[6] M. Jochum,et al. Long-term follow-up of aprotinin-specific immunoglobulin G antibodies after cardiac operations. , 1997, The Journal of thoracic and cardiovascular surgery.
[7] H. Lummis,et al. The use of low-dose aprotinin, epsilon-aminocaproic acid or tranexamic acid for prevention of mediastinal bleeding in patients receiving aspirin before coronary artery bypass operations. , 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[8] S. Bélisle,et al. Randomized, Placebo‐Controlled, Double‐Blind Study of an Ultra‐Low‐Dose Aprotinin Regimen in Reoperative and/or Complex Cardiac Operations , 1997, Journal of cardiac surgery.
[9] L. Cohn,et al. Aprotinin in primary valve replacement and reconstruction: a multicenter, double-blind, placebo-controlled trial. , 1996, The Journal of thoracic and cardiovascular surgery.
[10] D. Tempe,et al. Blood conservation in small adults undergoing valve surgery. , 1996, Journal of cardiothoracic and vascular anesthesia.
[11] R. E. Clark,et al. A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. , 1995, Circulation.
[12] S. Pugh,et al. A comparison of the effects of tranexamic acid and low-dose aprotinin on blood loss and homologous blood usage in patients undergoing cardiac surgery. , 1995, Journal of cardiothoracic and vascular anesthesia.
[13] P. Brady,et al. The use of ultra-low-dose aprotinin to reduce blood loss in cardiac surgery. , 1995, Journal of cardiothoracic and vascular anesthesia.
[14] J. Levy,et al. Pharmacokinetics of Aprotinin in Preoperative Cardiac Surgical Patients , 1994, Anesthesiology.
[15] C. Bailey,et al. Randomised placebo controlled double blind study of two low dose aprotinin regimens in cardiac surgery. , 1994, British heart journal.
[16] H. Redl,et al. Formation of cytokines by retransfusion of shed whole blood. , 1994, British journal of anaesthesia.
[17] D. Green,et al. Effect of recombinant aprotinin on platelet activation in patients undergoing open heart surgery. , 1993, Haemostasis.
[18] T. Misaki,et al. Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypass. , 1993, The Annals of thoracic surgery.
[19] E. Berreklouw,et al. Low-dose aprotinin in internal mammary artery bypass operations contributes to important blood saving. , 1992, The Annals of thoracic surgery.
[20] F. Loop,et al. Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study. , 1992, The Annals of thoracic surgery.
[21] W. Dietrich,et al. High-dose aprotinin in cardiac surgery: three years' experience in 1,784 patients. , 1992, Journal of cardiothoracic and vascular anesthesia.
[22] D. Royston. High-dose aprotinin therapy: a review of the first five years' experience. , 1992, Journal of cardiothoracic and vascular anesthesia.
[23] J. Soria,et al. Hemostasis in Patients Undergoing Extracorporeal Circulation: The Effect of Aprotinin (Trasylol) , 1991, Thrombosis and Haemostasis.
[24] L. V. von Segesser,et al. Low-dose aprotinin also allows reduction of blood loss after cardiopulmonary bypass. , 1991, The Journal of thoracic and cardiovascular surgery.
[25] M. Abdelnoor,et al. Conventional blood conservation techniques in 500 consecutive coronary artery bypass operations. , 1991, The Annals of thoracic surgery.
[26] J. E. Doran,et al. Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass. , 1991, The Journal of thoracic and cardiovascular surgery.
[27] P. Fondu,et al. Low-dose aprotinin for reduction of blood loss after cardiopulmonary bypass , 1991, The Lancet.
[28] K. Otani,et al. Lack of withdrawal symptoms after discontinuation of mianserin , 1991, The Lancet.
[29] C. Soria,et al. Differential redistribution of platelet glycoproteins Ib and IIb-IIIa after plasmin stimulation. , 1991, Blood.
[30] F. Sebening,et al. Influence of high-dose aprotinin treatment on blood loss and coagulation patterns in patients undergoing myocardial revascularization. , 1990, Anesthesiology.
[31] W. van Oeveren,et al. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. , 1990, The Journal of thoracic and cardiovascular surgery.
[32] J. Jones,et al. Effects of intraoperative plasmapheresis on blood loss in cardiac surgery. , 1990, The Annals of thoracic surgery.
[33] L. Donovan,et al. Autologous blood donations prior to elective cardiac surgery. Safety and effect on subsequent blood use. , 1989 .
[34] D. Cosgrove,et al. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). , 1989, The Journal of thoracic and cardiovascular surgery.
[35] R. Mammana,et al. Intraoperative autotransfusion in cardiac operations. Effect on intraoperative and postoperative transfusion requirements. , 1988, The Journal of thoracic and cardiovascular surgery.
[36] W. van Oeveren,et al. Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass. , 1987, The Annals of thoracic surgery.
[37] J. Rumberger,et al. Aprotinin for coronary artery bypass grafting: effect on postoperative renal function. , 1995, The Annals of thoracic surgery.
[38] E. Covino,et al. Low dose aprotinin as blood saver in open heart surgery. , 1991, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.